Evidence map›Paper›PMID 38711997›Full record

ArticleBioinformation2024

Linking elevated HbA1c with atherogenic lipid profile among high risk cardiovascular patients at Qassim, Saudi Arabia.

Rihab Akasha, Saheem Ahmad, Rnada Abdeen, Sara Abulgasim, Heba Barnawi, Nagwan Elhussein, Rehab Hussien A, Dina Nawaf Alshammari, Nancy Elafandy, Sultan Alouffi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Bioinformation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rihab AkashaDepartment of Clinical Laboratory Sciences,College of Applied Medical Sciences,University of Hail, Saudi Arabia.
Saheem AhmadDepartment of Clinical Laboratory Sciences,College of Applied Medical Sciences,University of Hail, Saudi Arabia.
Rnada AbdeenDepartment of Clinical Laboratory Sciences,College of Applied Medical Sciences,University of Hail, Saudi Arabia.
Sara AbulgasimDepartment of Clinical Laboratory Sciences,College of Applied Medical Sciences,University of Hail, Saudi Arabia.
Heba BarnawiDepartment of Clinical Laboratory Sciences,College of Applied Medical Sciences,University of Hail, Saudi Arabia.
Nagwan ElhusseinDepartment of Clinical Laboratory Sciences,College of Applied Medical Sciences,University of Hail, Saudi Arabia.
Rehab Hussien ADepartment of Clinical Laboratory Sciences,College of Applied Medical Sciences,University of Hail, Saudi Arabia.
Dina Nawaf AlshammariDepartment of Clinical Laboratory Sciences,College of Applied Medical Sciences,University of Hail, Saudi Arabia.
Nancy ElafandyDepartment of Clinical Laboratory Sciences,College of Applied Medical Sciences,University of Hail, Saudi Arabia.
Sultan AlouffiDepartment of Clinical Laboratory Sciences,College of Applied Medical Sciences,University of Hail, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The relationship between glycated hemoglobin (HbA1c) and an atherogenic lipid profile which is associated with a higher risk of cardiovascular disease is of interest. A retrospective cross-sectional study was conducted on 83 participants aged between 14 and 77 years. Their venous blood was drawn to determine the HbA1c and fasting lipid profile including total cholesterol triglycerides and high-density lipoprotein cholesterol (HDL-C) low-density lipoprotein cholesterol (LDL-C) non-HDL cholesterol and the LDL/HDL ratio were also calculated. The correlations between HbA1c levels and these lipid profile parameters were analyzed. The study showed a significant correlation between HbA1c and LDL-C non-HDL-C and the LDL/HDL ratio. Although there was no significant difference in total cholesterol levels among all groups the levels of total cholesterol and HbA1c were positively correlated. HDL-C exhibited direct correlations with HbA1c there was no correlation between HbA1c and clinical characteristics except for age. Data shows that HbA1c can be used as a predictor of dyslipidemia in diabetic patients there is a significant correlation between HbA1c and an atherogenic lipid profile which highlights the importance of glycemic control in reducing the risk of cardiovascular disease.

Indexed as

Atherogenic LipoproteinsHbA1cLDL cholesterolLipid ProfileNon-HDL cholesterol

Identifiers

PMID38711997
PMCPMC11069612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.